Chăm sóc đẳng cấp thế giới. Tiếp cận trực tiếp. Với một phần nhỏ chi phí.

Nguồn & Tài liệu tham khảo

1. [1]Newsweek & Statista, World's Best Hospitals 2026. South Korea: 7 hospitals in the global Top 100, 16 in the Top 250 — Samsung Medical Center #26, Asan Medical Center #28, Severance (Yonsei) #39, Seoul National University Hospital #41, SNU Bundang #54, Gangnam Severance #77, Ajou University Hospital #94. rankings.newsweek.com ↗
2. [2]Newsweek & Statista, World's Best Hospitals 2026 — Global Top 250, counted by country across all 250 ranks. USA 41, Germany 22, South Korea 16 (3rd of 32 nations), France 15, Japan 15, Italy 13, Spain 12, UK 11, Canada 10, Switzerland 8, Netherlands 8, Australia / Brazil / Austria 7 each, Sweden / Norway 5, Israel / Belgium / India / Colombia 4. Per-capita chart uses World Bank 2024 population and excludes nations under 20 million people. rankings.newsweek.com ↗
3. [3]World Bank, Total Population 2024 (SP.POP.TOTL). Used to normalize top-hospital counts per 10 million people. Korea 51.75M; USA 340.11M; Germany 83.52M; Japan 123.98M; France 68.55M; Italy 58.95M. data.worldbank.org ↗
4. [4]Newsweek & Statista, World's Best Smart Hospitals 2026. South Korea: 17 hospitals among the global Top 350, 6 in the Top 100 — Samsung Medical Center ranked #15 globally (No.1 in Korea for a 5th consecutive year). rankings.newsweek.com ↗
5. [5]Allemani C. et al., CONCORD-3, The Lancet (2018). Stomach-cancer 5-year age-standardized net survival: Korea ~69% — the highest in the world. Korea also leads in colon (72%) and rectal (71%) cancer survival. pmc.ncbi.nlm.nih.gov ↗
6. [6]Yoon Y-I. et al., Updates in Surgery (2024); Asan Medical Center. World's highest-volume living-donor liver transplant program — 6,000 LDLT cases analyzed; adult survival 1-yr 92.7%, 5-yr 85.9%. pubmed.ncbi.nlm.nih.gov ↗
7. [7]Kim H. et al., Scientific Reports (2024); Severance / Yonsei. 10,000 robotic transaxillary thyroid surgeries (2007–2023) — largest reported single-institution series. nature.com ↗
8. [8]NHS England, Referral to Treatment (RTT) Waiting Times (2025–26). A GP referral is required to see an NHS specialist; ~7.2M incomplete pathways, with 61.5% seen within the 18-week standard. england.nhs.uk ↗
9. [9]Fraser Institute, "Waiting Your Turn: Wait Times for Health Care in Canada, 2024." Median wait from GP referral to treatment: 30.0 weeks — the longest on record. (Fraser Institute is a free-market policy think tank.) fraserinstitute.org ↗
10. [10]National Health Insurance Service (NHIS), Korea — Insurance Benefits. Outpatient coinsurance: clinic 30%, hospital 40%, general hospital 50%, tertiary 60%. A standard clinic specialist visit costs the patient ~₩4,000–6,000 (~US$3–5). nhis.or.kr ↗
11. [11]HIRA / OECD Health at a Glance (2023). Koreans average ~18 outpatient visits per year — the highest in the OECD and roughly 3× the OECD average (~6.5). hira.or.kr ↗
12. [12]KHIDI, 2024. Over 1.17 million international patients visited Korea in 2024 — a record high; international patient centers commonly deliver consultation, diagnostics and a treatment plan within 24–48 hours. khidi.or.kr ↗
13. [13]US allogeneic stem-cell transplant cost — peer-reviewed (Transplant Cell Ther, 2023). Estimated lifetime medical cost of an allogeneic HCT patient in the ~$942k–$1.25M range. Compared with Korean international-patient estimates of ~$55k–$170k, this implies roughly an 85% saving. pmc.ncbi.nlm.nih.gov ↗
14. [14]Bookimed, Bone-Marrow Transplantation in the Republic of Korea (2026). International-patient estimates: overall ~$55k–$118k; related-donor $75k–$105k; per-clinic quotes up to ~$168k. Indicative figures, not guaranteed quotes. bookimed.com ↗
15. [15]MediGence / Bookimed (2026). Stage II gastric cancer (gastrectomy + stay + adjuvant chemo) — Korea ~$7k–$20k; Singapore ~$20k–$50k; Thailand ~$10k–$27k. International-patient estimates. medigence.com ↗
16. [16]Peer-reviewed gastric-cancer cost data (US & multicenter China). US comprehensive gastric-cancer management commonly $50k–$150k+; multicenter China data: Stage II direct cost ~$9,004. pubmed.ncbi.nlm.nih.gov ↗
17. [17]MDPI Cancers (2023), "Treatment Costs and Social Burden of Pancreatic Cancer." Pancreatic cancer (Whipple + chemotherapy): US Whipple resection median ~$57,893 plus chemotherapy ~$42k–$116k ⇒ ~$100k–$170k+; Singapore ~$37k–$85k. The Korea figure is a flagged estimate — no published Korean self-pay total was available. pmc.ncbi.nlm.nih.gov ↗
18. [18]Patients Beyond Borders / KHIDI. Major procedures in Korea are commonly estimated at ~30–70% below US prices; indicative estimates that vary by procedure and provider. patientsbeyondborders.com ↗

Lưu ý về dữ liệu: xếp hạng bệnh viện lấy từ Newsweek/Statista (World's Best Hospitals 2025–26 và World's Best Smart Hospitals 2026); bảng xếp hạng theo quốc gia đếm số bệnh viện của mỗi nước trong Top 250 toàn cầu 2026. Dữ liệu sống thêm từ CONCORD-3 (The Lancet, 2018). Số liệu tiếp cận và thời gian chờ từ NHS, Fraser Institute, NHIS và HIRA. So sánh chi phí điều trị kết hợp các nghiên cứu kinh tế y tế đã bình duyệt (cho Mỹ) với ước tính du lịch y tế / bệnh nhân quốc tế (Bookimed, MediGence và những nguồn khác) cho các nước châu Á; đây là khoảng tham khảo, không phải báo giá đảm bảo, và thay đổi theo bệnh nhân, thủ thuật và cơ sở. Con số ung thư tụy của Hàn Quốc là ước tính rõ ràng vì không có tổng công bố. Chỉ để tham khảo; hãy đối chiếu giá trị hiện hành với nguồn trước khi dùng chính thức.

© 2026 — Đại Hàn Dân Quốc · Lợi thế y tế